• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同来源的人骨髓间充质干细胞有多相似?一项比较研究综述。

How Similar are Human Mesenchymal Stem Cells Derived from Different Origins? A Review of Comparative Studies.

机构信息

Immunology Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Department of Medical Biotechnology and Nanotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

出版信息

Curr Stem Cell Res Ther. 2021;16(8):980-993. doi: 10.2174/1574888X16666210302151823.

DOI:10.2174/1574888X16666210302151823
PMID:33653253
Abstract

Mesenchymal stem/stromal cells (MSCs) are adult multipotent cells with self-renewal potential and the ability to differentiate into specialized cells. MSCs home in various tissues and can be isolated using simple methods. Because of this feasibility in the isolation and culture of MSCs in vitro, many scientists have focused on the therapeutic applications of MSCs for various diseases and conditions. The selection of the tissue source to obtain MSCs mainly depends on the availability of the tissue, the patient's health status, as well as the expertise of the researcher. However, some studies indicate that MSCs derived from different tissue sources are not the same and possess different regenerative capacities. Therefore, in this review, we have collected and summarized the results from studies that have performed head-to-head comparisons between MSCs isolated from different tissues. Despite the assessment method discrepancy between studies, results from these studies reveal that MSCs derived from different tissue sources are not the same. Some such as umbilical cord-derived MSCs and menstrual blood-derived MSCs were identified with robust angiogenic potentials. However, cord blood-derived MSCs possessed a strong cartilage repair capacity. Further investigations are required to establish certain capabilities for MSCs derived from a particular tissue origin. Nevertheless, it is recommended to consider the possibility of functional variations between MSCs isolated from distinct tissue origins when applying MSCs in clinics.

摘要

间充质干细胞(MSCs)是具有自我更新潜力和分化为特定细胞能力的成体多能细胞。MSCs 归巢于各种组织,并可采用简单的方法进行分离。由于在体外分离和培养 MSCs 的可行性,许多科学家专注于 MSC 对各种疾病和病症的治疗应用。MSC 组织来源的选择主要取决于组织的可用性、患者的健康状况以及研究人员的专业知识。然而,一些研究表明,源自不同组织来源的 MSCs 并不相同,并且具有不同的再生能力。因此,在这篇综述中,我们收集并总结了来自不同组织来源的 MSC 进行头对头比较的研究结果。尽管研究之间的评估方法存在差异,但这些研究的结果表明,源自不同组织来源的 MSCs 并不相同。一些组织来源的 MSCs,如脐带和月经血来源的 MSC,被鉴定具有强大的血管生成潜力。然而,脐血来源的 MSC 具有很强的软骨修复能力。需要进一步的研究来确定特定组织来源的 MSC 具有某些能力。尽管如此,当将 MSCs 应用于临床时,建议考虑源自不同组织来源的 MSC 之间功能变化的可能性。

相似文献

1
How Similar are Human Mesenchymal Stem Cells Derived from Different Origins? A Review of Comparative Studies.不同来源的人骨髓间充质干细胞有多相似?一项比较研究综述。
Curr Stem Cell Res Ther. 2021;16(8):980-993. doi: 10.2174/1574888X16666210302151823.
2
5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies.经5-氮杂胞苷处理的源自脐带、脐血和骨髓的人间充质干/祖细胞在体外并不能高频产生心肌细胞。
Vox Sang. 2008 Aug;95(2):137-48. doi: 10.1111/j.1423-0410.2008.01076.x. Epub 2008 Jun 28.
3
Heterogeneity of proangiogenic features in mesenchymal stem cells derived from bone marrow, adipose tissue, umbilical cord, and placenta.源自骨髓、脂肪组织、脐带和胎盘的间充质干细胞中促血管生成特征的异质性。
Stem Cell Res Ther. 2016 Nov 10;7(1):163. doi: 10.1186/s13287-016-0418-9.
4
Comparative analysis of mesenchymal stem cells derived from amniotic membrane, umbilical cord, and chorionic plate under serum-free condition.无血清条件下羊膜、脐带和胎盘绒毛膜来源间充质干细胞的比较分析。
Stem Cell Res Ther. 2019 Jan 11;10(1):19. doi: 10.1186/s13287-018-1104-x.
5
Mesenchymal Stem/Stromal Cells Derived from Human and Animal Perinatal Tissues-Origins, Characteristics, Signaling Pathways, and Clinical Trials.人及动物围生期组织来源的间充质干细胞:起源、特性、信号通路及临床试验。
Cells. 2021 Nov 23;10(12):3278. doi: 10.3390/cells10123278.
6
Umbilical cord mesenchymal stem cells: the new gold standard for mesenchymal stem cell-based therapies?脐带间充质干细胞:基于间充质干细胞疗法的新金标准?
Tissue Eng Part B Rev. 2014 Oct;20(5):523-44. doi: 10.1089/ten.TEB.2013.0664. Epub 2014 Apr 22.
7
Comparative separation methods and biological characteristics of human placental and umbilical cord mesenchymal stem cells in serum-free culture conditions.无血清培养条件下人胎盘和脐带间充质干细胞的比较分离方法和生物学特性。
Stem Cell Res Ther. 2020 May 19;11(1):183. doi: 10.1186/s13287-020-01690-y.
8
Isolation method and xeno-free culture conditions influence multipotent differentiation capacity of human Wharton's jelly-derived mesenchymal stem cells.分离方法和无血清培养条件影响人脐带华通氏胶间充质干细胞的多能分化能力。
Stem Cell Res Ther. 2013 Jul 11;4(4):81. doi: 10.1186/scrt232.
9
Umbilical cord tissue is a robust source for mesenchymal stem cells with enhanced myogenic differentiation potential compared to cord blood.脐带组织是间充质干细胞的丰富来源,与脐带血相比,其具有增强的成肌分化潜能。
Sci Rep. 2020 Nov 4;10(1):18978. doi: 10.1038/s41598-020-75102-9.
10
Generation of functional islets from human umbilical cord and placenta derived mesenchymal stem cells.从人脐带和胎盘来源的间充质干细胞生成功能性胰岛。
Methods Mol Biol. 2012;879:291-313. doi: 10.1007/978-1-61779-815-3_17.

引用本文的文献

1
Progress and Prospects in the Treatment of Lacrimal Gland Dysfunction Diseases: From Traditional Treatment Methods to Stem Cell and Organoid Therapies.泪腺功能障碍性疾病治疗的进展与展望:从传统治疗方法到干细胞与类器官疗法
Stem Cells Int. 2025 Aug 8;2025:6334284. doi: 10.1155/sci/6334284. eCollection 2025.
2
Efficacy of umbilical cord-derived mesenchymal stem cells and exosomes in conjunction with standard IBD drug on immune responses in an IBD mouse model.脐带间充质干细胞和外泌体联合标准炎症性肠病药物对炎症性肠病小鼠模型免疫反应的疗效
Stem Cell Res Ther. 2025 Jan 7;16(1):5. doi: 10.1186/s13287-024-04062-y.
3
Stimulating effect of nanocurcumin and crocin on proliferation and pluripotency of bone marrow-derived mesenchymal stem cells.
纳米姜黄素和藏红花素对骨髓间充质干细胞增殖和多能性的刺激作用。
Iran J Basic Med Sci. 2024;27(9):1187-1196. doi: 10.22038/IJBMS.2024.74397.16197.
4
Cartilage-Specific Gene Expression and Extracellular Matrix Deposition in the Course of Mesenchymal Stromal Cell Chondrogenic Differentiation in 3D Spheroid Culture.在 3D 球体培养中骨髓基质细胞软骨分化过程中软骨特异性基因表达和细胞外基质沉积。
Int J Mol Sci. 2024 May 23;25(11):5695. doi: 10.3390/ijms25115695.
5
Human umbilical cord-derived mesenchymal stem cells and auto-crosslinked hyaluronic acid gel complex for treatment of intrauterine adhesion.人脐带间充质干细胞与自交联透明质酸凝胶复合物治疗宫腔粘连
Aging (Albany NY). 2024 Apr 1;16(7):6273-6289. doi: 10.18632/aging.205704.
6
Chromosomal Instability in Various Generations of Human Mesenchymal Stem Cells Following the Therapeutic Radiation.治疗性放疗后不同代人间充质干细胞的染色体不稳定性
Stem Cells Int. 2023 Aug 29;2023:9991656. doi: 10.1155/2023/9991656. eCollection 2023.
7
Mesenchymal stem cell therapy in amyotrophic lateral sclerosis (ALS) patients: A comprehensive review of disease information and future perspectives.间充质干细胞疗法治疗肌萎缩侧索硬化症(ALS)患者:疾病信息与未来展望的全面综述
Iran J Basic Med Sci. 2023;26(8):872-881. doi: 10.22038/IJBMS.2023.66364.14572.
8
Effectiveness of RCTs Pooling Evidence on Mesenchymal Stem Cell (MSC) Therapeutic Applications During COVID-19 Epidemic: A Systematic Review.随机对照试验汇总证据对新冠疫情期间间充质干细胞治疗应用的有效性:一项系统评价
Biologics. 2023 May 18;17:85-112. doi: 10.2147/BTT.S404421. eCollection 2023.
9
Comparison of therapeutic effects of mesenchymal stem cells from umbilical cord and bone marrow in the treatment of type 1 diabetes.脐带间充质干细胞与骨髓间充质干细胞治疗 1 型糖尿病的疗效比较。
Stem Cell Res Ther. 2022 Aug 8;13(1):406. doi: 10.1186/s13287-022-02974-1.
10
Mesenchymal stromal cell therapy for COVID-19-induced ARDS patients: a successful phase 1, control-placebo group, clinical trial.间充质基质细胞治疗 COVID-19 诱导的 ARDS 患者:一项成功的 1 期、对照安慰剂组、临床试验。
Stem Cell Res Ther. 2022 Jun 28;13(1):283. doi: 10.1186/s13287-022-02920-1.